ABT logo Abbott Laboratories +
Abbott Laboratories
+

Abbott Laboratories (ABT) Business News

Track Abbott Laboratories in real time with a live news feed covering Abbott Laboratories stock news, official press releases, company announcements, and an archive of historical Abbott Laboratories news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
8:18 AM | Thursday | Jul 2, 2026 24/7 Wall Street

5 Underperforming Dividend Kings Offer Big Passive Income and Huge Total Return Potential

News Thumbnail
8:18 AM | Thursday | Jul 2, 2026 24/7 Wall Street

5 Underperforming Dividend Kings Offer Big Passive Income and Huge Total Return Potential

News Thumbnail
8:03 AM | Wednesday | Jul 1, 2026 24/7 Wall Street

Here Are Wednesday's Best Wall Street Analyst Research Calls: Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesforce, ServiceNow,SpaceX, and More

News Thumbnail
7:02 AM | Wednesday | Jul 1, 2026 Benzinga

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

News Thumbnail
11:43 AM | Monday | Jun 29, 2026 Fool - Investing News

3 No-Brainer Dividend Stocks to Buy Right Now

News Thumbnail
10:21 AM | Monday | Jun 29, 2026 Zacks Investment Research

How Abbott's Largest Segment Is Preparing for the Next Growth Phase

News Thumbnail
10:05 AM | Sunday | Jun 28, 2026 The Motley Fool

In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000

News Thumbnail
9:36 AM | Friday | Jun 26, 2026 Zacks Investment Research

Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?

News Thumbnail
9:00 AM | Thursday | Jun 25, 2026 PRNewsWire

Abbott hosts conference call for second-quarter earnings

News Thumbnail
9:56 AM | Wednesday | Jun 24, 2026 Zacks Investment Research

How Are Emerging Markets Supporting Abbott's EPD Momentum?

News Thumbnail
8:30 AM | Wednesday | Jun 24, 2026 PRNewsWire

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

News Thumbnail

5 Underperforming Dividend Kings Offer Big Passive Income and Huge Total Return Potential

24/7 Wall Street

8:18 AM | Thursday | Jul 2, 2026

news photo
Loading...

Passive income is characterized by its ability to generate revenue without requiring the earner's continuous active effort, making it a desirable financial strategy for those seeking to diversify their income streams or achieve financial independence.

Read full article redirect
8:18 AM | Thursday | Jul 2, 2026

5 Underperforming Dividend Kings Offer Big Passive Income and Huge Total Return Potential

24/7 Wall Street

Passive income is characterized by its ability to generate revenue without requiring the earner's continuous active effort, making it a desirable financial strategy for those seeking to diversify their income streams or achieve financial independence.

Read full article arrow
News Thumbnail
8:18 AM | Thursday | Jul 2, 2026

5 Underperforming Dividend Kings Offer Big Passive Income and Huge Total Return Potential

24/7 Wall Street

Passive income is characterized by its ability to generate revenue without requiring the earner's continuous active effort, making it a desirable financial strategy for those seeking to diversify their income streams or achieve financial independence.

Read full article arrow
News Thumbnail
8:03 AM | Wednesday | Jul 1, 2026

Here Are Wednesday's Best Wall Street Analyst Research Calls: Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesforce, ServiceNow,SpaceX, and More

24/7 Wall Street

Futures are trading lower as we get ready to start the third quarter after a record-setting second quarter that saw the Dow Jones Industrial Average close at 52,317, up 0.26% to finish the venerable index's best first half since 2021, while the Nasdaq finished the session at 26,213, up 1.52% for the tech-heavy index's best quarterly finish since 2020.

Read full article arrow
News Thumbnail
7:02 AM | Wednesday | Jul 1, 2026

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Read full article arrow
News Thumbnail
11:43 AM | Monday | Jun 29, 2026

3 No-Brainer Dividend Stocks to Buy Right Now

Fool - Investing News

AbbVie, J&J, and Pfizer are all reliable income plays in this choppy market.

Read full article arrow
News Thumbnail
10:21 AM | Monday | Jun 29, 2026

How Abbott's Largest Segment Is Preparing for the Next Growth Phase

Zacks Investment Research

ABT's Medical Devices unit builds on strong growth with new diabetes, heart rhythm and electrophysiology advances ahead of Q2 2026.

Read full article arrow
News Thumbnail
10:05 AM | Sunday | Jun 28, 2026

In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000

The Motley Fool

During times of market turmoil, investors cycle back into defensive, dividend-focused names like Abbott Laboratories. Besides Dividend King status and a moderately high dividend yield, this diversified healthcare stock also trades at a discount to peers like Johnson & Johnson.

Read full article arrow
News Thumbnail
9:36 AM | Friday | Jun 26, 2026

Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?

Zacks Investment Research

DXCM outpaces Abbott with expanding CGM access, new product launches and broader coverage, making it the stronger stock to watch now.

Read full article arrow
News Thumbnail
9:00 AM | Thursday | Jun 25, 2026

Abbott hosts conference call for second-quarter earnings

PRNewsWire

ABBOTT PARK, Ill., June 25, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2026 financial results on Thursday, July 16, before the market opens.

Read full article arrow
News Thumbnail
9:56 AM | Wednesday | Jun 24, 2026

How Are Emerging Markets Supporting Abbott's EPD Momentum?

Zacks Investment Research

ABT's Emerging Markets drive EPD growth, with strong branded generics demand, biosimilar expansion and new approvals boosting momentum.

Read full article arrow
News Thumbnail
8:30 AM | Wednesday | Jun 24, 2026

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

PRNewsWire

ALZpath Strengthens Market Leadership with Abbott Agreement to Help Enable Early Alzheimer's Diagnosis at Global Scale CARLSBAD, Calif., June 24, 2026 /PRNewswire/ -- ALZpath Inc.,  the leader in blood test-based diagnostic solutions for Alzheimer's disease, today announced a licensing agreement with Abbott (NYSE: ABT), a global healthcare leader, to incorporate ALZpath's proprietary phosphorylated Tau 217 (pTau217) antibody into the development of an in vitro diagnostic (IVD) test for Alzheimer's disease.

Read full article arrow
News Thumbnail